Press Releases

Panitch Schwarze Attorney Weihong Hsing Speaks on IP Protection in China

March 20, 2012

PHILADELPHIA (March 20, 2012)Dr. Weihong Hsing, Attorney at Panitch Schwarze Belisario and Nadel LLP, was a speaker at 21st Annual Partnerships in Clinical Trials on March 5 at the Orlando World Center in Orlando, Florida. Dr Hsing's presentation, "Protect Your Intellectual Property: Tools for Patent Protection When Conducting Trials in China," covered topics on the shifting trend in China from a country which primarily copied other people's products to one which plays an active role in creating new products. She also talked on the differing characteristics of this burgeoning IP nation from the U.S., and how foreign companies can protect their Intellectual Property rights and avoid infringement lawsuits when conducting clinical trials in China.

The Annual Partnerships in Clinical Trials is known as the premiere clinical trials meeting in the world drawing the attendance of nearly 2,000 participants from over 50 countries involved in the strategic decisions and operations of conducting global clinical trials.

About Panitch Schwarze Belisario & Nadel LLP – Panitch Schwarze Belisario & Nadel LLP is a boutique intellectual property law firm based in Philadelphia, PA and Wilmington, DE. Our attorneys provide strategic advice concerning litigation, licensing, and counseling services relating to patents, trademarks, copyrights, trade secrets, domain names, and internet issues domestically and internationally. We have experience across the sciences, in technology, and in branding, ranging from semiconductors and computer software to household products and toys.

Contact Us

By checking this box, I agree to the terms and conditions outlined on our Disclaimer page.
Email Disclaimer

Sending an email to our office does not create an attorney-client relationship, and none will be formed unless there is an expressed agreement between the firm and the client. Thus, we strongly advise against sending confidential or privileged information to us until you can establish such a relationship. Furthermore, we advise against sending privileged or confidential information through email at all, since we can in no way ensure the security of your email. In fact, neither this website nor the email system involved is encrypted, so you should not assume that your email is confidential. We cannot guarantee that someone else will not see it.

Do you agree to this Email Disclaimer?

I Agree I Do Not Agree